- From: Andrea Splendiani <andrea.splendiani@bbsrc.ac.uk>
- Date: Thu, 26 May 2011 13:40:09 +0000
- To: Helena Deus <helenadeus@gmail.com>
- Cc: (wrong string) ņa Aranguren <megana@fi.upm.es>, "public-semweb-lifesci@w3.org" <public-semweb-lifesci@w3.org>
- Message-ID: <339406287344259@jngomktg.net>
I'm not sure we need a different IG. If the focus is integration of data... environment and health are far... but in theory not that far... ciao, Andrea Il giorno 26/mag/2011, alle ore 14.31, Helena Deus ha scritto: > Hi, > > That is a very good point, thanks Mikel and Andrea! > Do you have pointers to such type of data? Shall we consider an IG for "basic" life sciences? > > The LS part of HCLS has indeed been gaining adepts rapidly and it may make sense to reflect that in the charter. > > Cheers, > Lena > > 2011/5/26 Mikel Egaņa Aranguren <megana@fi.upm.es> > Hi; > > I should attend the conference call but I just want to add that I concur with Andrea in that the HCLS IG should consider the environmental realm, since loads of new ecological/environment data, with new challenges to be addressed, are waiting to be represented semantically. That's precisely one of the lines we are trying to open here at OEG-UPM. > > Cheers > > > On og., 2011.eko mairen 26a 15:08, Andrea Splendiani wrote: > Hi, > > I see myself as more involved in the next incarnation of the charter ;) > Unfortunately, today is a travel day and I cannot attend the conference > call. > > I have two questions/ideas, which don't really map to the current > sub-groups, but just in case they ring some bell: > > -) Is the HCLS exclusively oriented on HeathCare ? (that is, is the "and" in > Heath Care and Life Sciences IG and AND or an OR ?). Here in Rothamsted, we > are just starting to evaluate the Ecological/Agricultural/Environmental > connections to Life Sciences. Does this fall into the remit of the IG group > ? > > -) Does the evaluation/ coordination of development of systems which link > information representation and analysis side fall within the remit of the IG > ? I think interfaces to linked data, as well as tools which can analyze > linked data are important to improve the acceptance of Semantic Web > technologies in the Life Sciences. > > ciao, > Andrea > > > > > Il giorno 24/mag/2011, alle ore 04.04, Eric Prud'hommeaux ha scritto: > > Hi all, as some of you reallize, the charter ends at the end of this > month. I've been polling around to see what alternative formulations > would give us the most resources and impact. In the process, I wrote > up some of our high-level use cases (elevator speeches) to help us > approach the relevant parties in pharmas, health services and > research:<http://www.w3.org/2011/05/HCLSIGUseCases>. > > I'd like to discuss the landscape and potential strategies with the > community. I'd particularly like to invite those who have been active > or see themselves as being active in the next incarnation of the group. > We'll discuss the current, fairly conservative draft charter > <http://www.w3.org/2011/05/HCLSIGCharter-proposal>, as well as ways to > optimize both its message and the paths for dissemination. An example > of a messaging alternative would be to characterize the HCLS IG work > in terms of e.g. overarching translational medicine use cases: > " > The W3C Semantic Web in Health Care and Life Sciences Interest Group > focuses on translational medicine use cases. The group will continue > the aggregation of cutting edge and traditional scientific knowledge > to meet use cases for researchers, care givers, patients and > regulatory agencies. Due to the scope and diversity of expertise > required to meet translational needs, the HCLS IG work is broken > down into discrete task forces focused on particular data > acquisition, modeling and integration requirements: > > Terminology - identifying and integrating identifiers for biological > processes, gross anatomy and medical procedures to promote > unification of domain data. > > LODD - curation of compounds, clinical trials and outcomes. > > BioRDF - modeling of biological processes and actors. > > Scientific Discourse - representation and tracking of the changing > landscape of scientific knowledge and the driving theora and > experiments. > > Translational Medicine - the oversight and high-level ontology that > connects these disciplines together in order to meet immediate and > long term needs from pharma, health care and other vested parties. > " > . Perhaps you all have some other ideas about how to tell a story > about our work which will serve to both draw people to our work and > our products and to help already interested parties find the task > forces which interest them. I of course want to draw an optimal > balance between doing work which motivates the participants and > focusing on tasks which will accelerate education and adoption by > important organizations. > > I'm sure you are all aware of my preference for technical work, but I > feel that this outreach can make us all ultimately more effective. I > will use the Thursday 26 May HCLS slot (11:00 EDT) to reach out to the > current HCLS IG community, and whomever else you folks elect to bring > along. Of course, I'll reserve extra teleconference slots, but please > RSVP to me privately so I can make a guess at how many ports to > reserve. Also, please provide what feedback you can before the > conference. Anything we take care of before will make the meeting more > efficient. > > Conference Details > > Date of Call: Thursday, May 26, 2011 > Time of Call: 11:00 am Eastern Time, 4 pm UK, 5 pm CET > Dial-In #: +1.617.761.6200 (Cambridge, MA) > [Note: limited access to European dial in numbers below] > Dial-In #: +33.4.26.46.79.03 (Nice, France) > Dial-In #: +44.203.318.0479 (Bristol, UK) > Participant Access Code: 4257 ("HCLS") > IRC Channel: irc.w3.org port 6665 channel #HCLS (see W3C IRC page for > details, or see Web IRC), Quick Start: Use > http://www.mibbit.com/chat/?server=irc.w3.org:6665&channel=%23hcls for > IRC access. > Duration: ~1 hour > Convener: Eric Prud'hommeaux > Scribe: TBD > > HCLS IG charter/strategy discussion > -- > -ericP > > Andrea Splendiani > Senior Bioinformatics Scientist > Centre for Mathematical and Computational Biology > +44(0)1582 763133 ext 2004 > andrea.splendiani@bbsrc.ac.uk > > > > > > > > -- > Mikel Egaņa Aranguren, PhD > http://mikeleganaaranguren.com > > Marie Curie post-doc at Ontology Engineering Group, UPM > http://www.oeg-upm.net/ > > > > > > -- > Helena F. Deus > Post-Doctoral Researcher at DERI/NUIG > http://lenadeus.info/ > Andrea Splendiani Senior Bioinformatics Scientist Centre for Mathematical and Computational Biology +44(0)1582 763133 ext 2004 andrea.splendiani@bbsrc.ac.uk
Received on Thursday, 26 May 2011 13:41:20 UTC